Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck

Mario Eisenberger, Maria Jacobs

Research output: Contribution to journalArticle

Abstract

A substantial proportion of patients with squamous cell carcinoma of the head and neck have extensive locoregional disease at presentation. While extensive surgical procedures may completely eradicate local disease with acceptable morbidity for smaller tumors, in patients with stage III and IV disease, high local relapse rates and relatively short survival times still characterize the course of the majority of such patients. For patients with locally unresectable disease, the combined use of chemotherapy and radiation has resulted in encouraging data both in terms of local control and survival. Combined-modality programs frequently employ platinum coordination complexes, and standard or hyperfractionated radiotherapy toxicity data suggest that the overall tolerance of such programs is acceptable and, more important, long-term follow-up has shown that function can be largely preserved. In this review we illustrate the experience with combined single-agent chemotherapy and radiotherapy, and discuss the methodologic difficulties of clinical trials in this setting. We describe our experience with combined carboplatin and simultaneous conventional radiation in patients with extensive unresectable locoregional disease. Encouraging results and modest toxicity clearly support further testing with this approach, especially in patients with less advanced and bulky disease.

Original languageEnglish (US)
Pages (from-to)41-46
Number of pages6
JournalSeminars in Oncology
Volume19
Issue number4 SUPPL. 11
StatePublished - 1992
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Radiation
Drug Therapy
Radiotherapy
Therapeutics
Survival
Carboplatin
Coordination Complexes
Platinum
Clinical Trials
Morbidity
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck. / Eisenberger, Mario; Jacobs, Maria.

In: Seminars in Oncology, Vol. 19, No. 4 SUPPL. 11, 1992, p. 41-46.

Research output: Contribution to journalArticle

@article{705b75ba7f8441f6aae02ac93a455828,
title = "Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck",
abstract = "A substantial proportion of patients with squamous cell carcinoma of the head and neck have extensive locoregional disease at presentation. While extensive surgical procedures may completely eradicate local disease with acceptable morbidity for smaller tumors, in patients with stage III and IV disease, high local relapse rates and relatively short survival times still characterize the course of the majority of such patients. For patients with locally unresectable disease, the combined use of chemotherapy and radiation has resulted in encouraging data both in terms of local control and survival. Combined-modality programs frequently employ platinum coordination complexes, and standard or hyperfractionated radiotherapy toxicity data suggest that the overall tolerance of such programs is acceptable and, more important, long-term follow-up has shown that function can be largely preserved. In this review we illustrate the experience with combined single-agent chemotherapy and radiotherapy, and discuss the methodologic difficulties of clinical trials in this setting. We describe our experience with combined carboplatin and simultaneous conventional radiation in patients with extensive unresectable locoregional disease. Encouraging results and modest toxicity clearly support further testing with this approach, especially in patients with less advanced and bulky disease.",
author = "Mario Eisenberger and Maria Jacobs",
year = "1992",
language = "English (US)",
volume = "19",
pages = "41--46",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "4 SUPPL. 11",

}

TY - JOUR

T1 - Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck

AU - Eisenberger, Mario

AU - Jacobs, Maria

PY - 1992

Y1 - 1992

N2 - A substantial proportion of patients with squamous cell carcinoma of the head and neck have extensive locoregional disease at presentation. While extensive surgical procedures may completely eradicate local disease with acceptable morbidity for smaller tumors, in patients with stage III and IV disease, high local relapse rates and relatively short survival times still characterize the course of the majority of such patients. For patients with locally unresectable disease, the combined use of chemotherapy and radiation has resulted in encouraging data both in terms of local control and survival. Combined-modality programs frequently employ platinum coordination complexes, and standard or hyperfractionated radiotherapy toxicity data suggest that the overall tolerance of such programs is acceptable and, more important, long-term follow-up has shown that function can be largely preserved. In this review we illustrate the experience with combined single-agent chemotherapy and radiotherapy, and discuss the methodologic difficulties of clinical trials in this setting. We describe our experience with combined carboplatin and simultaneous conventional radiation in patients with extensive unresectable locoregional disease. Encouraging results and modest toxicity clearly support further testing with this approach, especially in patients with less advanced and bulky disease.

AB - A substantial proportion of patients with squamous cell carcinoma of the head and neck have extensive locoregional disease at presentation. While extensive surgical procedures may completely eradicate local disease with acceptable morbidity for smaller tumors, in patients with stage III and IV disease, high local relapse rates and relatively short survival times still characterize the course of the majority of such patients. For patients with locally unresectable disease, the combined use of chemotherapy and radiation has resulted in encouraging data both in terms of local control and survival. Combined-modality programs frequently employ platinum coordination complexes, and standard or hyperfractionated radiotherapy toxicity data suggest that the overall tolerance of such programs is acceptable and, more important, long-term follow-up has shown that function can be largely preserved. In this review we illustrate the experience with combined single-agent chemotherapy and radiotherapy, and discuss the methodologic difficulties of clinical trials in this setting. We describe our experience with combined carboplatin and simultaneous conventional radiation in patients with extensive unresectable locoregional disease. Encouraging results and modest toxicity clearly support further testing with this approach, especially in patients with less advanced and bulky disease.

UR - http://www.scopus.com/inward/record.url?scp=0026671410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026671410&partnerID=8YFLogxK

M3 - Article

C2 - 1509280

AN - SCOPUS:0026671410

VL - 19

SP - 41

EP - 46

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 4 SUPPL. 11

ER -